Quốc gia: New Zealand
Ngôn ngữ: Tiếng Anh
Nguồn: Medsafe (Medicines Safety Authority)
Loperamide hydrochloride 2mg
Multichem NZ Limited
Loperamide hydrochloride 2 mg
2 mg
Tablet
Active: Loperamide hydrochloride 2mg Excipient: Brilliant blue FCF Colloidal silicon dioxide Lactose monohydrate Magnesium stearate Povidone Purified talc Quinoline yellow Sodium starch glycolate Starch
Blister pack, PVC/PVDC/AL, 16 tablets
Pharmacy only
Pharmacy only
Olon SpA
Relief of diarrhoea
Package - Contents - Shelf Life: Blister pack, PVC/PVDC/AL - 16 tablets - 36 months from date of manufacture stored at or below 25°C protect from light and moisture. Protect from heat
2002-10-07
Multichem New Zealand Ltd Page 1 of 3 NEW ZEALAND CONSUMER MEDICINE INFORMATION NŌDIA _Loperamide hydrochloride 2 mg tablets_ WHAT IS IN THIS LEAFLET? This leaflet answers some common questions about NŌDIA. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor or pharmacist has weighed the risks of you taking NŌDIA against the benefits it can offer you. If you have any concerns about using NŌDIA, ask your doctor or pharmacist. Keep this leaflet with your medicine. You may want to read it again. WHAT NŌDIA IS USED FOR AND HOW IT WORKS NŌDIA tablets contain loperamide hydrochloride, a medicine that makes the stools more solid and less frequent. It does this by restoring the muscle contractions of the intestine to normal. This allows the bowel time to absorb water and produce a more solid stool. NŌDIA IS USED TO TREAT SUDDEN (ACUTE) DIARRHOEA. NŌDIA is also prescribed by doctors to treat long-lasting (chronic) diarrhoea or diarrhoea in patients who have had part of their intestines removed by surgery (intestinal resection). BEFORE YOU TAKE NŌDIA When you must not take it Do not take NŌDIA if: - you have an allergy to loperamide hydrochloride or any of the other ingredients listed at the end of this leaflet - you are constipated or have to avoid being constipated - you have severe diarrhoea with blood in the stools or a fever - your doctor has diagnosed an inflammation of the lower bowel such as ulcerative colitis or antibiotic associated pseudomembranous colitis - you are breast-feeding - the packaging is torn or shows signs of tampering. Do not take NŌDIA after the expiry or use- by date printed on the pack. Medicines may not be effective if taken after their expiry date. Do not give NŌDIA to children under the age of 12 years. Before you take it Tell your doctor or pharmacist if you have allergies to any other medicines, foods, preservatives or dyes. Symptoms of an allergic reaction may i Đọc toàn bộ tài liệu
NEW ZEALAND DATA SHEET NODIA Page 1 of 10 1. NAME OF THE MEDICINAL PRODUCT Nōdia2 mg tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2 mg loperamide hydrochloride and typically weighs 160 mg. For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Green, capsule-shaped tablets with a break-line on one side. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Nōdia is indicated for the symptomatic control of acute and chronic diarrhoea. In patients with an ileostomy, colostomy or other intestinal resection it can be used to reduce the number and volume of stools and to harden their consistency. 4.2 Dose and method of administration Adults and children over 12 years Acute diarrhoea: The initial dose is 2 tablets followed by 1 tablet after every subsequent loose stool. Chronic diarrhoea: The initial dose is 2 tablets daily; this initial dose should be adjusted until 1-2 solid stools a day are obtained which is usually achieved with a maintenance dose of 1-6 tablets daily. The maximum dose for acute and chronic diarrhoea is 8 tablets daily. Do not halve the tablets. Dose equivalence when the tablet is divided has not been established. Patients should be advised to drink plenty of clear fluids, water, unsweetened juices or clear soups. 4.3 Contraindications Nōdia is contraindicated in patients with known hypersensitivity to Ioperamide or to any of the excipients. Nōdia should not be used as the primary therapy: • in patients with acute dysentery, which is characterised by blood in stools and high fever; • in patients with acute ulcerative colitis; NEW ZEALAND DATA SHEET NODIA Page 2 of 10 • in patients with bacterial enterocolitis caused by invasive organisms including _Salmonella, _ _Shigella _and _Campylobacter; _ • in patients with pseudomembranous colitis associated with the use of broad-spectum antibiotics. In general, Nōdia should not be used when inhibition of peristalsis is to be avoided due to the possible risk of significant sequelae Đọc toàn bộ tài liệu